A dimmer switch for reward: the vagus sets the gain

In a Trends in Neurosciences Article Wang, Liu, and Bai, simplify and summarize the extensive experiments of Onimus, Arrivet and Gangarossa. Here is a Claude Sonnet 4.6 reduction of Wang et al:

The Vagus Nerve as a Dimmer Switch for Reward

We tend to blame mood or willpower when a favorite treat loses its appeal. But a recent mouse study by Onimus and colleagues suggests the deciding factor may lie in signals traveling from the gut — specifically, in the tonic influence of the vagus nerve on the brain's entire reward circuitry.

The finding is counterintuitive. Neuroscientists have long known that specific vagal sensory neurons detect nutrients like sugar and fat and transmit that information to mesolimbic dopamine circuits. The new twist: when the authors severed subdiaphragmatic vagal input, the dopamine system didn't just lose its food-reward signal — it lost global responsiveness. Dopamine surges in the nucleus accumbens (NAc) were blunted in response to cocaine, morphine, and stress, not just food. Motivation dropped, conditioned place preference weakened, and reward-seeking behavior declined broadly.

The circuit-level changes were correspondingly deep. VTA dopamine neurons showed reduced firing and diminished excitatory input. NAc medium spiny neurons lost dendritic spine density. The mesolimbic pathway was structurally remodeled; the nigrostriatal (motor) pathway was not. The vagus, it turns out, doesn't just relay specific gut signals — it constitutively maintains the architecture and excitability of the reward system itself.

What vagal signals carry this tonic influence? Candidates include nutrient-sensing neurons, immune-status signals via cytokine-sensitive vagal afferents, and gut microbial metabolites — any or all of which could set the system's baseline gain.

The clinical implications are intriguing. Reduced vagal tone is well-documented in depression and anxiety. Vagus nerve stimulation is already used for treatment-resistant depression — possibly, this work suggests, by restoring mesolimbic responsiveness rather than targeting mood directly. And the emotional blunting and anhedonia sometimes reported with GLP-1 agonists (Ozempic, etc.) may reflect modulation of this same vagal-mesolimbic axis.

The takeaway: the path to reward is gated by the gut. The vagus nerve acts less like a specific nutrient sensor and more like a dimmer switch — setting the overall gain of the brain's motivation system from the inside of the body outward.